Comparative efficacy and safety of direct oral anticoagulants versus aspirin for secondary stroke prevention in patients with embolic stroke of undetermined source: a systematic review and network meta-analysis of randomized controlled trials

Read full text Summarise with VIRAT
Authors: Prince Kusimw'iragi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This systematic review and network meta-analysis aims to compare the efficacy and safety of direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban) versus aspirin for secondary stroke prevention in adults with embolic stroke of undetermined source (ESUS). A systematic search of major databases will identify relevant randomized controlled trials. A frequentist network meta-analysis will be conducted to estimate the relative effects of treatments, including indirect comparisons between DOACs, and to rank them according to efficacy and safety outcomes. The results will provide a comprehensive synthesis of the available evidence to inform clinical decision-making and identify optimal antithrombotic strategies in ESUS.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Acute Ischemic Stroke Management Venous Thromboembolism Diagnosis and Management

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint